.Basilea Pharmaceutica's work establishing brand new antifungals has actually gotten a notable boost...
.Possessing presently gathered up the USA rights to Capricor Therapeutics' late-stage Duchenne muscu...
.After pushing the selection meeting for Applied Therapeutics' metabolic condition medication govore...
.Novo Nordisk is actually proceeding its own press in to genetic medications, accepting to compensat...
.Innovent Biologics has helped make the scenario that its own checkpoint inhibitor-cytokine combinat...
.A phase 3 test of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate ...
.Five months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotec...
.Ascendis Pharma has become a prospective threat to BioMarin's Voxzogo, reporting phase 3 growth dis...
.Though Alkeus Pharmaceuticals' dental eye condition resource neglected to significantly decrease ge...
.With a triad of biotechs striking the Nasdaq on Friday, it was simple to skip a smaller-scale socia...
.Immune system checkpoint preventions are actually the superheroes of cancer treatment. Drugs like B...
.Welcome to recently's Chutes & Ladders, our summary of notable management hirings, firings as we...
.Regeneron is back along with lasting follow-up for its own LAG-3 prevention and also PD-1 inhibitor...
.AstraZeneca has actually shared an early examine the performance of its internal antibody-drug conj...
.After revealing a stage 3 launch based on favorable midstage end results, iTeos as well as GSK are ...
.The FDA needs to be more open and also collaborative to discharge a rise in approvals of uncommon h...
.It's an unusually busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara Reh...
.Atea Pharmaceuticals' antiviral has actually neglected another COVID-19 trial, but the biotech stil...
.Neurocrine Biosciences' schizophrenia course pivot has failed. The biotech was unable to imitate th...
.Sanofi has made a late access to the radioligand party, paying 100 million europeans ($ 110 thousan...